Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sandoz
Sandoz
US Tariffs Will Raise Drug Prices for Patients, Sandoz CEO Says
MSN/Reuters
Mon, 04/28/25 - 09:35 am
Sandoz
drug pricing
tariffs
Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug
Investing.com
Mon, 04/14/25 - 09:42 am
Sandoz
antitrust
legal
Amgen
Enbrel
generics
Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June
Fierce Pharma
Wed, 01/29/25 - 11:20 am
Sandoz
Amgen
Celltrion
patents
biosimilars
Prolia
Xgeva
Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation
Fierce Pharma
Tue, 12/17/24 - 12:03 pm
Sandoz
price fixing
legal
Sandoz, Liquidia score $137M win against United in years-long generic Remodulin dispute
Fierce Pharma
Mon, 09/16/24 - 10:22 pm
Sandoz
United Therapeutics
generics
PAH
Treprostinil
As Sandoz contract winds down, GSK will close antibiotics plant in UK
Fierce Pharma
Mon, 09/9/24 - 07:18 pm
GSK
Sandoz
UK
drug manufacturing
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Sandoz
earnings
biosimilars
Humira
AbbVie
Novartis
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Sandoz
earnings
biosimilars
AbbVie
Humira
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes
Thu, 05/2/24 - 11:34 am
CVS Caremark
AbbVie
Humira
biosimilars
Hyrimoz
Sandoz
PBMs
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
Sandoz completes acquisition of ranibizumab biosimilar
Healio
Mon, 03/4/24 - 11:52 pm
Sandoz
ranibizumab
Coherus Biosciences
Cimerli
Sandoz will pay $265m to settle price fixing case in US
Pharmaphorum
Thu, 02/29/24 - 09:44 am
Sandoz
price fixing
legal
Pennsylvania
Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina
Fierce Pharma
Thu, 02/8/24 - 09:57 pm
Sandoz
layoffs
North Carolina
generics
drug manufacturing
Sandoz makes its first post-spinout acquisition
Pharmaphorum
Mon, 01/22/24 - 11:12 am
Sandoz
M&A
Coherus
biosimilars
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
AbbVie
Rinvoq
patents
legal
Sandoz
Sun Pharma
Intas Pharmaceuticals
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters
Wed, 10/4/23 - 09:43 am
Novartis
Sandoz
spinoffs
Novartis confirms Sandoz spin-off for October 4, 2023
Reuters
Mon, 09/25/23 - 07:45 pm
Novartis
Sandoz
spinoffs
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Tue, 09/5/23 - 11:18 am
Novartis
Sandoz
spinoffs
generics
biosimilars
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »